Delivery Order SPE2DB20D9354-SPE2DB25FX7V9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Mirena 52 mg contraceptive systems. The award was issued under a firm fixed-price contract with an ultimate completion date of September 4, 2025. This delivery order represents a discrete procurement from DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, which is valued at approximately $500 million and valid through November...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, valued at $10,415.40 with a firm fixed-price structure, was issued on September 23, 2025, with an ultimate completion date of October 15, 2025. This award carries no set-aside designation and represents a single delivery order under DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems, with an ultimate completion date of October 6, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group, a woman-owned small business based in Park Ridge, Illinois, will perform the work at its primary location. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and was awarded on September 12, 2025. No set-aside designation was applied to this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. The contract, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. This firm fixed-price delivery order, issued on July 3, 2025, with an ultimate completion date of July 25, 2025, represents a continuation of ongoing pharmaceutical supply services to federal healthcare facilities. The order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at approximately $26,039 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, issued on August 3, 2025, with an ultimate completion date of August 22, 2025, is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $500 million through November 2026. The delivery order carries no set-aside...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX7V9Delivery Order
The Defense Logistics Agency issued a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, awarded on July 17, 2025, represents a standalone purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The order will be fulfilled from the contractor's facility in Park Ridge, Illinois, with an ultimate completion date of August 7, 2025. No set-aside designation was utilized for this award. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in 2001, maintains a robust federal procurement portfolio focused on supplying medical products and medications to military and federal healthcare systems. The company holds a strategic position within DLA's pharmaceutical supply chain under the SPE2DB program, enabling issuance of delivery orders for branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities nationwide. This particular order for Mirena contraceptive systems aligns with the company's established track record of delivering specialized pharmaceutical products to federal healthcare providers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/17/25 |